Education Library

Education Library

Education on Demand
Discover education about Impella® devices wherever you want and whenever you want.

ECpella in Refractory Cardiac Arrest

Prof. Carsten Skurk, MD, and Tharusan Thevathasan, MD, discuss ECMELLA support—VA-ECMO and Impella CP® heart pump —in refractory. cardiac arrest.

All Posts

Ergebnisse filtern





May 18, 2023

A “Treasure Trove” of Complete Revascularization Data

Vasileios Panoulas, MD, discusses an individual patient data pooling from the PROTECT II RCT, PROTECT III, and RESTORE EF trials released at EuroPCR 2023.

May 11, 2023

FAQ: Anticoagulation

This FAQ addresses thrombus formation and anticoagulation for blood-contacting medical devices, such as the Impella® heart pump.

May 11, 2023

Heparin-Free Purge: Sodium Hydrogencarbonate-Based Purge Solution

Jeremy Moretz, PharmD, BCCP, describes the Impella® heart pump purge system and explains that while Impella has historically required a heparin-based purge solution, a sodium hydrogencarbonate-based (also called "bicarbonate") purge solution is now a viable alternative.

May 11, 2023

Heparin-free Purge Help Manage Anticoagulation in Patients Supported with Impella Heart Pumps

Prof. Dr. Christophe Vandenbriele discusses managing anticoagulation in patients supported with Impella heart pumps and the use of bicarbonate-based purge fluid for Impella.

April 3, 2023

Early Left Ventricular Unloading Improves Survival in Patients With Cardiogenic Shock Undergoing Extracorporeal Membrane Oxygenation (ECMO)

Dr. Andreas Götzenich interviews Dr. Benedikt Schrage from Hamburg on the topic "Early left ventricular unloading improves survival in patients with cardiogenic shock undergoing extracorporeal membrane oxygenation (ECMO)".

March 30, 2023

Improving Survival in Cardiogenic Shock—A Propensity Score-Matched Analysis of the Impact of an Institutional Allocation Protocol to Short-Term Mechanical Circulatory Support

In this paper, Sascha Ott and colleagues describe a standard operating procedure (SOP) they developed for determining the temporary mechanical circulatory support (tMCS) strategy for patients in cardiogenic shock (CS).

March 29, 2023

ECpella in Refractory Cardiac Arrest

Prof. Carsten Skurk, MD, and Tharusan Thevathasan, MD, discuss ECMELLA support — VA ECMO and Impella CP® heart pump — in refractory cardiac arrest.

March 27, 2023

How to Achieve Better Outcomes in PCCS

Prof. Dr. med. Gregor Warnecke discusses how to achieve better outcomes in patients with postcardiotomy cardiogenic shock (PCCS).

March 27, 2023

The ECMELLA 2+ Concept

Prof. Evgenij Potapov explains how “ECMELLA 2+” achieves over 50% survival in patients with very severe cardiogenic shock while minimizing complications and enabling mobilization.

March 27, 2023

Prof. Evgenij Potapov : SOPs for Cardiogenic Shock

Prof. Evgenij Potapov discusses improved survival in patients who were treated at his institution with standard operating procedures (SOPs) for cardiogenic shock.

March 15, 2023

85% Survival with Impella 5.5® with SmartAssist® Heart Pump ECpella

Alan Gass, MD, discusses data from successful management of patients with Impella 5.5® with SmartAssist® heart pump and ECMO.

March 15, 2023

ELSO 2022 Q&A with Evgenij Potapov, Roberto Lorusso, and Alan Gass

Roberto Lorusso, MD, Alan Gass, MD, and Evgenij Potapov, MD, discuss topics related to ECpella and LV unloading in this Q&A session from ELSO 2022.

March 15, 2023

ECMO-CS Trial: VA ECMO in Rapidly Deteriorating or Severe Cardiogenic Shock

Prof. Jan Belohlavek, MD, discusses ECMO CS trial results comparing immediate VA ECMO with conservative therapy allowing VA ECMO downstream in severe cardiogenic shock.

January 24, 2023

Specific Clinical Vignettes in High-Risk Protected Percutaneous Coronary Intervention

This article presents 3 case vignettes that provide practical insights and reinforce best practices. The authors emphasize that several cardiac and patient-related factors come into play when considering patients for Protected percutaneous coronary intervention (PCI).

January 24, 2023

Optimal Bail-out and Complication Management Strategies in Protected High-Risk Percutaneous Coronary Intervention With the Impella Heart Pump

In this article the authors describe techniques for Impella heart pump removal with or without pre-closure and discuss how to prevent and manage complications associated with large-bore femoral access.

Discover Online Education on Demand

Explore case clubs, webinars and masterclasses.

Subscribe for Our Healthcare Professional Newsletter

By subscribing you will receive our HeartRecovery newsletter for healthcare professionals with latest Impella® device news about recordings, interviews, upcoming and past events or clinical evidence.


A Community Created by Physicians for Physicians

CAMP PCI was developed by physicians for physicians in an effort to respond to a growing crisis in coronary artery disease and heart failure.


Discover further resources like brochures, data sheets and indications for use.